KMB (Kimberly-Clark Corporation): Themes, ETFs, and Basket Ideas
Last updated June 2026
Short answer
What does Kimberly-Clark Corporation do?
Kimberly-Clark is a consumer staples company that makes and sells personal care and tissue products under household brand names. Its portfolio includes Huggies diapers, Pull-Ups training pants, Kotex feminine care, Depend and Poise adult incontinence products, Kleenex tissues, Cottonelle and Scott bath tissue, and Viva paper towels. The company organizes around three segments: Personal Care (its largest and most profitable), Consumer Tissue, and a professional/away-from-home business serving offices, restaurants, and institutions (sold under the Kimberly-Clark Professional banner). Roughly half of revenue comes from outside North America, with meaningful exposure to developing and emerging markets where category penetration is still rising. Kimberly-Clark makes money by selling repeat-purchase, non-discretionary household essentials at scale, leaning on brand strength, retail distribution, and manufacturing efficiency. The business is a classic defensive staple: steady demand, modest organic growth, and a long dividend history. Headquartered in Irving, Texas, it has been a Dividend Aristocrat for decades.
Where is Kimberly-Clark Corporation heading?
1. Defensive, repeat-purchase demand.
Diapers, tissue, and feminine and incontinence care are non-discretionary essentials bought regardless of the economic cycle. This gives Kimberly-Clark predictable volumes and pricing power during inflation, since households rarely trade down entirely out of these categories. The recurring nature of demand supports stable cash flow that funds the long-running dividend.
2. Emerging-market category growth.
About half of sales come from outside North America, including markets where diaper and feminine-care penetration remains low and rising with incomes. As middle classes expand in Latin America, Asia, and parts of Africa, per-capita consumption of these categories grows structurally. This is the company's main organic volume-growth lever beyond developed-market pricing.
3. Margin and portfolio focus.
Kimberly-Clark has pursued cost-savings programs and is sharpening its focus on higher-margin personal care, including a move to separate or restructure parts of the tissue business. Premiumization (Huggies Special Delivery, higher-tier feminine care) and supply-chain efficiency are levers to expand margins even when volume growth is modest.
4. Dividend Aristocrat status.
Kimberly-Clark has raised its dividend for more than five decades, making it a core holding in dividend-growth and defensive income strategies. The combination of a steady payout, share buybacks, and resilient free cash flow is the central appeal for income-oriented investors.
Risks worth tracking: Kimberly-Clark sells largely commoditized products where private-label store brands compete aggressively on price, capping pricing power and pressuring volumes when consumers trade down. Input costs (pulp, resin, energy) and currency swings hit margins directly given heavy emerging-market exposure. Organic growth is structurally slow, so the stock behaves like a bond proxy and can lag in risk-on markets and underperform when interest rates rise. Major customers like Walmart hold negotiating leverage, and birth-rate declines in developed markets pressure the diaper category over time.
Earnings and valuation (approximate, early 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Kimberly-Clark Corporation's investor relations page or your broker.
- Revenue (TTM): ~$20 billion
- Operating margin: ~16%
- Net income (TTM): ~$2.5 billion
- P/E (TTM): ~18x
- Dividend yield: ~3.5%
- Dividend growth streak: 50+ consecutive years (Dividend Aristocrat)
- Free cash flow: ~$2 billion annually
Kimberly-Clark trades at a defensive-staples multiple, lower than faster-growing consumer names but supported by a high, durable dividend yield. The valuation reflects slow organic growth offset by predictable cash flow and decades of dividend increases. It tends to be valued like a bond proxy, with the multiple sensitive to interest rates and the dividend yield as the primary anchor for income investors.
KMB's competitors
Personal care and diapers
Procter & Gamble (Pampers, Always) is the largest global competitor and directly challenges Huggies and Kotex. Essity (TENA, Libresse) competes in feminine and incontinence care, particularly in Europe. Unicharm is a strong rival in Asian diaper and personal-care markets.
Tissue and towels
Georgia-Pacific (Quilted Northern, Brawny, owned by Koch) and Procter & Gamble (Charmin, Bounty) are the main branded competitors in bath tissue and paper towels. Private-label store brands from Walmart, Costco, and grocers compete heavily on price across all tissue categories.
Professional / away-from-home
In the institutional and commercial tissue and dispenser business, Kimberly-Clark Professional competes mainly with Essity (Tork) and Georgia-Pacific Professional for offices, healthcare, and food-service accounts.
Using KMB in a Walnut basket
The most useful question to ask about a single stock is rarely “will it go up?”. It's “does this fit a thesis I actually believe in, and how do I size it alongside other stocks that fit the same thesis?” That's what Walnut is built for.
Open the AI assistant on Walnut and describe a thesis (for example: “the AI infrastructure buildout”, “dividend growth large-caps”, “global semiconductors”) where KMB would naturally fit. The AI proposes 5 to 6 constituents with target weights, you review, and you can fund the basket through your broker once you're ready.
Build a basket around KMB with Walnut
Use Kimberly-Clark Corporation as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is KMB's ticker symbol?
+
KMB, listed on the New York Stock Exchange. Officially Kimberly-Clark Corporation, headquartered in Irving, Texas. It trades during US market hours and is available at every major US brokerage.
What does Kimberly-Clark do?
+
Kimberly-Clark makes and sells personal care and tissue products including Huggies diapers, Kotex and Poise feminine and incontinence care, Kleenex tissues, Cottonelle and Scott bath tissue, and Viva towels. It also runs a professional away-from-home business. About half of sales come from outside North America.
Who are Kimberly-Clark's main competitors?
+
Procter & Gamble (Pampers, Charmin, Bounty) is the largest rival across diapers, tissue, and feminine care. Essity (TENA, Tork) competes in incontinence and professional products, Georgia-Pacific in tissue and towels, and Unicharm in Asian personal care. Private-label store brands compete on price.
Does Kimberly-Clark pay a dividend?
+
Yes. Kimberly-Clark is a Dividend Aristocrat that has raised its dividend for more than 50 consecutive years, currently yielding around 3.5%. The dividend is the central appeal for income and dividend-growth investors and is funded by steady free cash flow.
Is Kimberly-Clark a Dividend Aristocrat?
+
Yes. With more than five decades of consecutive annual dividend increases, KMB qualifies as a Dividend Aristocrat and a Dividend King. It is a frequent holding in dividend-growth ETFs and funds focused on consistent payout growth.
Is Kimberly-Clark a consumer staples stock?
+
Yes. Under GICS classification, Kimberly-Clark is in the Consumer Staples sector (household and personal products). Its products are non-discretionary essentials, which makes it a defensive holding that tends to hold up better than discretionary names during downturns.
Which ETFs hold Kimberly-Clark?
+
KMB appears in broad market funds like VOO and VTI at small weights, in the consumer-staples fund XLP at a more meaningful weight, and in dividend-focused funds such as NOBL (Dividend Aristocrats), VYM, and SCHD when it screens favorably on yield and dividend-growth metrics.
What is Kimberly-Clark's dividend yield?
+
Approximately 3.5% as of early 2026. The yield is high relative to the broad market, reflecting the defensive, slow-growth profile. As a bond-proxy staple, the yield is the main valuation anchor and tends to move inversely with the stock price.
Is Kimberly-Clark recession-resistant?
+
Relatively, yes. Diapers, tissue, and feminine and incontinence care are essentials that households keep buying through downturns, giving Kimberly-Clark stable volumes and pricing power. The stock is not immune to drawdowns, but its underlying demand is more durable than most discretionary consumer businesses.
Which thematic baskets typically include Kimberly-Clark?
+
Two themes on Walnut. Dividend growth, given the 50-plus-year increase streak and steady yield, and Consumer staples / defensive, given the non-discretionary product portfolio. KMB is often used as a stability anchor alongside higher-growth holdings.
How is Kimberly-Clark affected by inflation?
+
Input costs like pulp, resin, and energy feed directly into Kimberly-Clark's cost base, so commodity inflation can compress margins. The company offsets this with price increases and cost-savings programs, but private-label competition limits how much it can pass through, so margins can lag input cost spikes.
Is Kimberly-Clark a good stock to buy?
+
Descriptive, not a recommendation. Kimberly-Clark is a defensive consumer-staples company with non-discretionary products, a 50-plus-year dividend-growth record, and a yield around 3.5%, offset by slow organic growth, private-label competition, and sensitivity to commodity costs and interest rates. Whether it fits a portfolio depends on your goals, time horizon, and risk tolerance. Walnut is informational, not investment advice.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Kimberly-Clark Corporation's investor relations page or your broker before making investment decisions.